Gene therapy of the other genome: the challenges of treating mitochondrial DNA defects

Area of Science:

• Genetics
• Molecular Biology
• Human Health

Background:

• Human mitochondrial DNA (mtDNA), a small circular molecule, plays a crucial role in cellular function despite its limited size.
• Defects in mtDNA are linked to diverse and severe clinical symptoms, particularly impacting the neuromuscular system.
• Diagnosing mtDNA diseases and developing effective therapies remain significant challenges in clinical practice.

Purpose of the Study:

• To review the unique challenges in correcting mitochondrial DNA (mtDNA) mutations.
• To summarize current gene therapy approaches for mitochondrial genome disorders.
• To highlight the nascent stage of mitochondrial gene therapy.

Main Methods:

• Literature review of current research on mtDNA mutations and gene therapy.
• Analysis of the specific hurdles in developing therapies for the mitochondrial genome.
• Synthesis of existing strategies for mitochondrial gene therapy.

Main Results:

• mtDNA mutations can lead to a wide spectrum of clinical manifestations with varied onset.
• Clinical diagnosis of mtDNA-related diseases is complex and challenging.
• Effective therapeutic strategies for mtDNA diseases are largely unavailable.

Conclusions:

• Gene therapy for mitochondrial DNA defects is an emerging field with significant obstacles.
• Understanding the unique challenges of mtDNA gene therapy is crucial for future therapeutic development.
• Further research is needed to advance treatments for mitochondrial genome disorders.